Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

Invasive fungal infections are another top concern, as outlined by the World Health Organization’s Fungal Priority Pathogens ...

The modified vaccinia Ankara-Bavarian Nordic mpox vaccine (MVA-BN; Jynneos) generated robust immune responses in adolescents ...

Oral cefixime is a third-generation cephalosporin that has a similar antibacterial spectrum to ceftriaxone. Cefixime is ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

Clesrovimab, formerly known as MK-1654, is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody.

Early antiviral therapy with obeldesivir was safe and well tolerated in patients at high risk for severe COVID-19 and ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Older adults who received the bivalent BNT162b2 vaccine were less likely to develop long COVID symptoms follow acute ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

Vaccination for influenza, SARS-CoV-2, and respiratory syncytial virus is less likely with an increasing social vulnerability index and Black race.

Otsuka has reported positive interim results from its Phase III trial evaluating sibeprenlimab, a treatment for adults with ...